| Southcoast Pharmacy | |
| 101 Page St, New Bedford, Massachusetts 02740 | |
| (508) 961-5449 |
| Name | Southcoast Pharmacy |
|---|---|
| Organization Name | Southcoast Hospitals Group Inc |
| Location | 101 Page St, New Bedford, Massachusetts 02740 |
| Type | Pharmacy |
| Phone | (508) 961-5449 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
A Wisconsin study found that take-home educational materials designed for the state's minority children with asthma do not adequately address the cultural and linguistic issues unique to racial/ethnic minority groups.
Soligenix, Inc. (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need, announced today that it has enrolled and treated all patients in the Phase 1 Study BDP-PCD-01; the first clinical study for development of SGX203 (oral beclomethasone 17,21-dipropionate or oral BDP) for the treatment of pediatric Crohn's disease.
Research involving participants of Britain's oldest running birth cohort study has revealed that changes in blood pressure in those as young as 36 are linked to markers of poorer brain health in later life.
InVivo Therapeutics Holdings Corp. (NVIV) announced today that it has received conditional approval from the Food and Drug Administration for proposed changes to the protocol and supporting documents for the safety trial of its first investigational product, a degradable polymer scaffold for spinal cord injury.
› Verified 7 days ago
| NPI Number | 1376565366 |
| Organization Name | SOUTHCOAST HOSPITALS GROUP INC |
| Doing Business As | SOUTHCOAST PHARMACY |
| Type | Pharmacy |
| Address | 101 Page St, New Bedford, MA 02740 |
| Phone Number | 508-973-5449 |
News Archive
A Wisconsin study found that take-home educational materials designed for the state's minority children with asthma do not adequately address the cultural and linguistic issues unique to racial/ethnic minority groups.
Soligenix, Inc. (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need, announced today that it has enrolled and treated all patients in the Phase 1 Study BDP-PCD-01; the first clinical study for development of SGX203 (oral beclomethasone 17,21-dipropionate or oral BDP) for the treatment of pediatric Crohn's disease.
Research involving participants of Britain's oldest running birth cohort study has revealed that changes in blood pressure in those as young as 36 are linked to markers of poorer brain health in later life.
InVivo Therapeutics Holdings Corp. (NVIV) announced today that it has received conditional approval from the Food and Drug Administration for proposed changes to the protocol and supporting documents for the safety trial of its first investigational product, a degradable polymer scaffold for spinal cord injury.
› Verified 7 days ago
News Archive
A Wisconsin study found that take-home educational materials designed for the state's minority children with asthma do not adequately address the cultural and linguistic issues unique to racial/ethnic minority groups.
Soligenix, Inc. (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need, announced today that it has enrolled and treated all patients in the Phase 1 Study BDP-PCD-01; the first clinical study for development of SGX203 (oral beclomethasone 17,21-dipropionate or oral BDP) for the treatment of pediatric Crohn's disease.
Research involving participants of Britain's oldest running birth cohort study has revealed that changes in blood pressure in those as young as 36 are linked to markers of poorer brain health in later life.
InVivo Therapeutics Holdings Corp. (NVIV) announced today that it has received conditional approval from the Food and Drug Administration for proposed changes to the protocol and supporting documents for the safety trial of its first investigational product, a degradable polymer scaffold for spinal cord injury.
› Verified 7 days ago
Rite Aid Pharmacy 10206 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 565 Mill St, New Bedford, Massachusetts 02740 Phone: (508) 996-5781 | |
Rite Aid Pharmacy 10209 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1207 Acushnet Ave, New Bedford, Massachusetts 02746 Phone: (508) 999-5067 | |
Rite Aid Pharmacy 10205 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 824 Purchase St, New Bedford, Massachusetts 02740 Phone: (508) 992-2422 | |
Cvs Pharmacy #00789 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 136 Ashley Blvd, New Bedford, Massachusetts 02746 Phone: (508) 996-2094 | |
Cvs Pharmacy #00799 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 786 Ashley Blvd, New Bedford, Massachusetts 02745 Phone: (508) 998-3831 |